Anti-CMV drug trials back on-line.

  • Published 1996 in
    GMHC treatment issues : the Gay Men's Health…

Abstract

Fomivirsen (formerly ISIS 2922), an antisense RNA molecule designed to attach to CMV, has been reinstated in several clinical trials. The trials are testing formivirsen's effect at low dosages in persons with early, non-sight threatening CMV retinitis. The new trials were initiated as a result of earlier tests indicating positive responses when fomivirsen… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics